HIGHLIGHTS
- who: Sabrina Ilham from the Department of Pharmacotherapy, College of Pharmacy, LSSkaggs Pharmacy Institute, University of Utah, , E, Salt Lake City, UT, USA have published the article: Cancer incidence in immunocompromised patients: a single-center cohort study, in the Journal: (JOURNAL) of February/20,/2018
- what: The aim of this study was to evaluate and compare cancer risk in three patient groups: recipients of SOT/HSCT, patients with PID/SID and patients treated with TNF-i therapy.
- how: The potential confounding effects were tested in multivariable Cox regression model.
- future: Future . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.